CLC Number:
| [1] 全军传染病专业委员会,新突发传染病中西医临床救治课题组.腺病毒感染诊疗指南[J]. 解放军医学杂志,2013,38(7):529-534. [2] 腺病毒呼吸道感染预防控制技术指南编写审定专家组. 人腺病毒呼吸道感染预防控制技术指南[J]. 中华预防医学杂志,2019,53(11):1088-1093. [3] 胡鹏. 宏基因组分析和诊断技术概述[N]. 中国医药报,2020-02-25(4). [4] 俞越, 石静萍, 祝东林. 脑脊液二代测序在病毒性脑炎与自身免疫性脑炎鉴别中的应用:基于5例患者的诊治经过[J]. 中国实用神经疾病杂志,2019,22(21):2327-2333. YUYue, SHI Jingping, ZHU Donglin. The implication of CSF next-generation sequencing in the differentiation between viral encephalitis and autoimmune encephalitis:based on the diagnosis and treatment of 5 cases[J]. Chinese Journal of Practical Nervous Diseases, 2019,22(21):2327-2333. [5] 田李均, 曹志龙, 徐俊贤, 等. mNGS辅助诊断巨细胞病毒感染相关性成人噬血细胞综合征1例并文献复习[J]. 江苏医药,2019,45(9):968-970. TIAN Lijun, CAO Zhilong, XU Junxian, et al. MNGS assisted in the diagnosis of adult hemophagocytic syndrome associated with cytomegalovirus infection in 1 case and literature review [J]. Jiangsu Medical Journal, 2019, 45(9):968-970. [6] Fan Wu, Su Zhao, Bin Yu, et al. A new coronavirus associated with human respiratory disease in China[J]. Nature Publishing Group UK, 2020, 579(7798):1-8. [7] Echavarría Marcela. Adenoviruses in immunocompromised hosts.[J]. Clin Microbiol Rev, 2008, 21(4):704-715. [8] Naesens L, Lenaerts L, Andrei G, et al. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues.[J]. Antimicrob. Agents Chemother, 2005, 49(3):1010-1016. [9] Morfin F, Dupuis-Girod S, Mundweiler S, et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.[J]. Antivir Ther, 2005, 10(2):225-229. [10] Gavin PJ, Katz Ben Z. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children [J]. Pediatrics, 2002, 110(1 Pt 1):e9. doi: 10.1542/peds.110.1.e9. [11] Kim SJ, Kim K, Park SB, et al. Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia[J]. PLoS One, 2015, 10(4):e122642. doi: 10.1371/journal.pone.0122642. [12] Lynch JP, Fishbein M, Echavarria M. Adenovirus[J]. Semin Respir Crit Care Med, 2011, 32(4):494-510. [13] 张志强, 翟永志, 陈歆, 等. 成人腺病毒B组55型重症肺炎11例诊治分析[J]. 中国全科医学, 2013, 16(12B):4200-4203. ZHANG Zhiqiang, ZHAI Yongzhi, CHEN Xin, et al. Diagnosis and treatment of 11 cases of severe human adenovirus type 55 pneumonia [J]. Chinese General Practice, 2013, 16(12B):4200-4203. [14] 赵春洪, 张志强, 翟永志, 等. 青壮年腺病毒B组55型重症肺炎临床特征分析[J]. 解放军医学院学报, 2014, 35(7):663-666. ZHAO Chunhong, ZHANG Zhiqiang, ZHAI Yongzhi, et al. Clinical characteristics of severe human adenovirus type 55 pneumonia[J]. Academic Journal of Chinese PLA Medical School, 2014, 35(7):663-666. [15] Ison MG. Adenovirus infections in transplant recipients[J]. Clin Infect Dis, 2006, 43(3):331-339. [16] Echavarría Marcela. Adenoviruses in immunocompromised hosts.[J]. Clin Microbiol Rev, 2008, 21(4):704-715. [17] Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery[J]. Blood, 2002, 100(5):1619-1627. [18] Heemskerk B, Lankester AC, van Vreeswijk T, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients[J]. J Infect Dis, 2005, 191(4):520-530. [19] Van Tol MJ, Claas EC, Heemskerk B, et al. Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity[J]. Bone Marrow Transplant, 2005, 35(Suppl 1):S73-S76. [20] Papadopoulou A, Gerdemann U, Katari UL, et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT[J]. Sci Transl Med, 2014, 6(242):242ra83. doi: 10.1126/scitranslmed.3008825. [21] Gerdemann U, Katari UL, Papadopoulou A, et al. Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.[J]. Mol Ther, 2013, 21(11):2113-2121. [22] Feucht J, Opherk K, Lang P, et al. Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT [J]. Blood, 2015, 125(12):1986-1994. |
| [1] | MENG Wei, WU Dawei, SHAN Tichao, ZHANG Fan, GUO Haipeng, LIU Yu, DING Shifang, ZHAI Qian. Tigecycline in treating ventilator-associated pneumonia in critically ill patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 71-75. |
| [2] | WANG Jing, GAO Guixin, WAN Yunyan, LIU Qinghua, YAO Zhouhong, LIN Dianjie. Effect of Yiqihuoxue-Yangyinjiedu recipe on expressions of TGF-β1 and TNF-α in radiation-induced lung injury [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 13-18. |
| [3] | WU Qian1, DING Qi-cui2, SONG Guo-dong1, WANG Wei1. Clinical aspects and prognostic factors of senile chronic-onset post-stroke pneumonia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 75-79. |
| [4] |
CHEN Hong, LIU Qing-hua, GUO Hai-sheng, LI Fang, KANG Yan-meng, LIN Dian-jie.
Associations of interleukin-6 and soluble E-selectin with severity and outcome of pneumonia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 82-. |
| [5] | LIN Ling-bo1， XIONG Chun-mei1， LI Jian-zhi1， LIU Kai2， XIAO Lian-xiang2， LIN Xiang-tao2 . Imaging characteristics of pneumonia from influenza A (H1N1) virus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(9): 136-139. |
| [6] | DU Li-ming, ZHOU Zhen, WANG Zeng, XIE De-rong. Complicated parapneumonic effusions treated by medical thoracoscopy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(9): 82-. |
| [7] | WAN Bing,ZHENG Jin-xu,HUANG Xin-jian,YAN Yu-lan,WU Jian-nong. Effect of Urokinase on bleomycin-induced pulmonary fibrosis and the expression of transforming growth factor-β1 in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(12): 1243-1246. |
| [8] | SUI Xiangyu, ZHANG Xiangchun, ZHANG Guangyong, HU Sanyuan, WANG Yanlei, DAI Yong. Preliminary study in the protective role of p120 catenin in inflammatory lung injury [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 41-44. |
|
||
